Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for...

Area of Science:

• Cardiology
• Clinical Risk Stratification
• Health Economics

Background:

• ST-segment elevation myocardial infarction (STEMI) management often involves prolonged hospital stays.
• Risk stratification is crucial for optimizing patient care and resource allocation post-primary angioplasty.

Purpose of the Study:

• To develop a practical risk score for patients with STEMI undergoing primary angioplasty.
• To evaluate the feasibility and cost-effectiveness of early discharge for low-risk STEMI patients.

Main Methods:

• A prognostic score was developed based on 30-day mortality in 1791 STEMI patients treated with primary angioplasty.
• Key predictors of mortality included age, anterior infarction, Killip class, ischemic time, postprocedural TIMI flow, and multivessel disease.
• Cost analysis compared conventional care with early discharge (48-72 hours) for low-risk patients.

Main Results:

• The developed score identified 73.4% of patients as low-risk (score ≤3) with high discriminatory capacity (c-statistic=0.907).
• Low-risk patients had very low 30-day mortality rates (0.1% at 2 days, 0.2% by 10 days).
• Early discharge was found to be cost-effective, saving lives at an incremental cost of $194,933 per life saved.

Conclusions:

• The new score is a practical tool for risk stratification in STEMI patients post-primary angioplasty.
• It enables safe early discharge for a significant number of low-risk patients.
• Implementation impacts clinical decision-making and healthcare costs positively.